Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix ® in Healthy Adult Volunteers

Conditions:   Shingles;   Herpes Zoster;   Vaccine-Preventable Diseases Interventions:   Biological: Z-1018;   Biological: Shingrix Sponsor:   Dynavax Technologies Corporation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials